Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α

The therapeutic efficacy of the AZT and IFN combination in ATL presumably reflects the inhibition of RT-related functions. HTLV-1–RT activity from short-term cultured PBMCs may represent a predictive correlate of clinical response to AZT/IFN in ATL patients.

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Macchi, Beatrice, Balestrieri, Emanuela, Frezza, Caterina, Grelli, Sandro, Valletta, Elena, Marçais, Ambroise, Marino-Merlo, Francesca, Turpin, Jocelyn, Bangham, Charles R., Hermine, Olivier, Mastino, Antonio, Bazarbachi, Ali
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2017
Matèries:
Stimulus Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728049/
https://ncbi.nlm.nih.gov/pubmed/29296718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016001370
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars